Verrica Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CALIGAN PARTNERS LP | 05/15/2026 | 923.91 K | $4.89 M | 0.00% | 8.67% |
| AFFINITY ASSET ADVISORS, LLC | 05/14/2026 | 707.34 K | $3.74 M | 0.00% | 6.64% |
| CANNELL CAPITAL LLC | 05/15/2026 | 685.12 K | $3.62 M | 100.00% | 6.43% |
| ARMISTICE CAPITAL, LLC | 05/15/2026 | 518.18 K | $2.74 M | -53.69% | 4.86% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 05/15/2026 | 471.56 K | $2.49 M | 0.00% | 4.43% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2026 | 280.73 K | $1.49 M | 0.00% | 2.64% |
| 05/15/2026 | 188.76 K | $998.53 K | 100.00% | 1.77% | |
| DAFNA CAPITAL MANAGEMENT LLC | 05/15/2026 | 153.71 K | $813.14 K | -11.38% | 1.44% |
| MARSHALL WACE, LLP | 05/15/2026 | 140.50 K | $743.23 K | 64.95% | 1.32% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 138.92 K | $734.97 K | 105.32% | 1.30% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 05/14/2026 | 99.74 K | $527.60 K | -71.80% | 0.94% |
| SQUAREPOINT OPS LLC | 05/15/2026 | 75.21 K | $397.85 K | 126.05% | 0.71% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 65.10 K | $344.38 K | 100.00% | 0.61% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 50.66 K | $268.00 K | -57.15% | 0.48% |
| JANE STREET GROUP, LLC | 05/12/2026 | 49.21 K | $260.33 K | -51.62% | 0.46% |
| BLACKROCK, INC. | 05/13/2026 | 38.55 K | $203.95 K | 578.15% | 0.36% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 32.36 K | $171.18 K | 22.58% | 0.30% |
| NORTHERN TRUST CORP | 05/14/2026 | 31.58 K | $167.06 K | 57.71% | 0.30% |
| STATE STREET CORP | 05/15/2026 | 28.92 K | $152.97 K | 23.15% | 0.27% |
| MARINER, LLC | 05/13/2026 | 24.54 K | $129.84 K | 0.00% | 0.23% |
| MORGAN STANLEY | 05/15/2026 | 22.39 K | $118.42 K | 1.71% | 0.21% |
| LEGACY TRUST | 04/14/2026 | 17.23 K | $91.17 K | 0.00% | 0.16% |
| VERDAD ADVISERS, LP | 05/15/2026 | 12.10 K | $64.00 K | 100.00% | 0.11% |
| BECK MACK & OLIVER LLC | 05/12/2026 | 12.00 K | $63.48 K | 0.00% | 0.11% |
| UBS GROUP AG | 05/05/2026 | 4.27 K | $22.59 K | 17,691.67% | 0.04% |
| CAPITAL ANALYSTS, LLC | 05/14/2026 | 1.50 K | $8.00 K | 0.00% | 0.01% |
| ROYAL BANK OF CANADA | 05/15/2026 | 965 | $5.00 K | 131.97% | 0.01% |
| VANGUARD GLOBAL ADVISERS, LLC | 05/08/2026 | 862 | $4.56 K | 100.00% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 856 | $4.53 K | -74.39% | 0.01% |
| SALOMON & LUDWIN, LLC | 05/11/2026 | 290 | $1.59 K | 0.00% | 0.00% |
| NEW ENGLAND CAPITAL FINANCIAL ADVISORS LLC | 04/27/2026 | 200 | $1.06 K | 0.00% | 0.00% |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 05/01/2026 | 175 | $961 | 0.00% | 0.00% |
| FORTITUDE FAMILY OFFICE, LLC | 04/16/2026 | 127 | $672 | -79.11% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 110 | $582 | 0.00% | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 05/08/2026 | 102 | $540 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 05/13/2026 | 47 | $224 | 0.00% | 0.00% |
| OPTIVER HOLDING B.V. | 06/02/2026 | 31 | $164 | 0.00% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 05/15/2026 | 26 | $114 | 100.00% | 0.00% |
| MAI CAPITAL MANAGEMENT | 05/15/2026 | 2 | $11 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| BARCLAYS PLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 05/13/2026 | 0 | $0 | -100.00% | 0.00% |
| OMERS ADMINISTRATION CORP | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
| MAN GROUP PLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| QUADRATURE CAPITAL LTD | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| WALLEYE CAPITAL LLC | 05/13/2026 | 0 | $0 | -100.00% | 0.00% |
Verrica Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 65 institutional investors and hedge funds held shares of Verrica Pharmaceuticals Inc. The most heavily invested institutionals were:
Caligan Partners LP: 923,910
Affinity Asset Advisors, LLC: 707,338
CANNELL CAPITAL LLC: 685,123
ARMISTICE CAPITAL, LLC: 518,181
Velan Capital Investment Management LP: 471,559
BOOTHBAY FUND MANAGEMENT, LLC: 280,734
44.85% of Verrica Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 6.03 M shares in the last 24 months. This purchase volume represents approximately $34.25 M in transactions.